FDA Approved: ANAGRELIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ANAGRELIDE submitted by Chartwell RX, LLC under ANDA076683. This action completes the supplemental approval proc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• ANAGRELIDE (Anagrelide)

Snippet

SUPPL AP for ANAGRELIDE (ANAGRELIDE)